What are the main predictors of in-hospital mortality in patients with infective endocarditis: a review

Scandinavian Cardiovascular Journal

Volumn 52, Issue 2, 2018, Pages 58-68

  Mistiaen, Wilhelm P ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Hogeschool Antwerpen   (Belgium)

Author keywords

hemodynamic status; hospital mortality; Infective endocarditis

Indexed keywords

BACTERIAL ENDOCARDITIS; CIRCULATION; HEART FAILURE; HEART LEFT VENTRICLE; HEMODYNAMIC PARAMETERS; HOSPITAL MORTALITY; HUMAN; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK; SCORING SYSTEM; SYSTEMATIC REVIEW; WEB OF SCIENCE; ADOLESCENT; ADULT; AGED; CHILD; CLINICAL DECISION MAKING; ENDOCARDITIS; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HOSPITALIZATION; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; PROPENSITY SCORE; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TIME TO TREATMENT; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLINICAL DECISION-MAKING; ENDOCARDITIS; FEMALE; HEMODYNAMICS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROPENSITY SCORE; RISK FACTORS; TIME FACTORS; TIME-TO-TREATMENT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 85044535993     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017431.2018.1433318     Document Type: Review

References (50)

1. Adademir T, Tuncer EY, Tas S, et al. Surgical treatment of aortic valve endocarditis: a 26-year experience. Rev Bras Cir Cardiovasc. 2014;29:16–24.
2. Ota T, Gleason TG, Salizzoni S, et al. Midterm surgical outcomes of non-complicated active native multivalve endocarditis: single-center experience. Ann Thorac Surg. 2011;91:1414–1419.
3. Rasmussen RV, Bruun LE, Lund J, et al. The impact of cardiac surgery in native valve infective endocarditis: Can euroSCORE guide patient selection? Int J Cardiol. 2011;149:304–309.
4. Carugati M, Bayer AS, Miró JM, on behalf of the International Collaboration on Endocarditis, et al. High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the International collaboration on endocarditis. Antimicrob Agents Chemother. 2013;57:6213–6222.
5. Korem M, Israel S, Gilon D, et al. Epidemiology of infective endocarditis in a tertiary-center in Jerusalem: a 3-year prospective survey. Eur J Int Med. 2014;25:550–555.
6. Ternhag A, Cederström A, Törner A, et al. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One. 2013;8:e67519.
7. Dunne B, Marr T, Kim D, et al. Infective endocarditis. Heart Lung Circ. 2014;23:628–635.
8. Murashita T, Sugiki H, Kamikubo Y, et al. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes. Eur J Cardiothorac Surg. 2004;26:1104–1111.
9. Barsic B, Dickerman S, Krajinovic V, for the International Collaboration on Endocarditis–Prospective Cohort Study (ICE-PCS) Investigators, et al. Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clinical Infectious Diseases. 2013;56:209–217.
10. García-Cabrera E, Fernández-Hidalgo N, Almirante B, on behalf of the Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases (SAEI) and the Spanish Network for Research in Infectious Diseases (REIPI), et al. Neurological complications of infective endocarditis risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127:2272–2284.
11. Kiefer T, Park L, Tribouilloy C, for the ICE-PCS Investigators, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239–2247.
12. Grubitzsch H, Schaefer A, Melzer C, et al. Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment. J Thorac Cardiovasc Surg. 2014;148:2052–2059.
13. Musci M, Hübler M, Amiri A, et al. Surgical treatment for active infective prosthetic valve endocarditis: 22-year single-centre experience. Eur J Cardiothorac Surg. 2010;38:528–538.
14. Leontyev S, Borger MA, Modi P, et al. Surgical management of aortic root abscess: a 13-year experience in 172 patients with 100% follow-up. J Thorac Cardiovasc Surg. 2012;143:332–337.
15. Lalani T, Cabell CH, Benjamin DK, for the International Collaboration on Endocarditis–Prospective Cohort Study (ICE-PCS) Investigators, et al. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation. 2010;121:1005–1013.
16. Leontyev S, Borger MA, Modi P, et al. Redo aortic valve surgery: influence of prosthetic valve endocarditis on outcomes. J Thorac Cardiovasc Surg. 2011;142:99–105.
17. Wilbring M, Tugtekin SM, Alexiou K, et al. Composite aortic root replacement for complex prosthetic valve endocarditis: initial clinical results and long-term follow-up of high-risk patients. Ann Thorac Surg. 2012;94:1967–1974.
18. Tugtekin S, Matschke K, Daubner D, et al. Prosthetic valve endocarditis: importance of surgical treatment. Thorac Cardiovasc Surg. 2007;55:94–98.
19. Koeda C, Tashiro A, Itoh T, et al. Mild renal dysfunction on admission is an important prognostic predictor in patients with infective endocarditis: a retrospective single-center study. Intern Med. 2013;52:1013–1018.
20. Marks DJB, Hyams C, Koo CY, et al. Clinical features, microbiology and surgical outcomes of infective endocarditis: a 13-year study from a UK tertiary cardiothoracic referral centre. Q J Med. 2015;108:219–229.
21. Spiliopoulos K, Giamouzis G, Haschemi A, et al. Surgical management of infective endocarditis: early and long-term mortality analysis: single-center experience and brief literature review. Hellenic J Cardiol. 2014;55:462–474.
22. Gaca JG, Sheng S, Daneshmand MA, et al. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thorac Cardiovasc Surg. 2011;141:98–106.
23. Chirouze C, Alla F, Fowler VG, Jr.,on behalf of the ICE Prospective Investigators, et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the international collaboration of endocarditis–prospective cohort study. Clin Infect Dis. 2015;60:741–749.
24. Machado MN, Arruda Nakazone M, Murad-Júnior JA, et al. Surgical treatment for infective endocarditis and hospital mortality in a Brazilian single-center. Rev Bras Cir Cardiovasc. 2013;28:29–35.
25. Pang PYK, Sin YK, Lim CH, et al. Surgical management of infective endocarditis: an analysis of early and late outcomes. Eur J Cardiothorac Surg. 2015;47:826–832.
26. Caes F, Bové T, Van Belleghem Y, et al. Reappraisal of a single-centre policy on the contemporary surgical management of active infective endocarditis. Interact Cardiovasc Thorac Surg. 2014;18:169–176.
27. Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466–2473.
28. Ohara T, Nakatani S, Kokubo Y, CADRE Investigators, et al. Clinical predictors of in-hospital death and early surgery for infective endocarditis: results of CArdiac Disease REgistration (CADRE), a nation-wide survey in Japan. Int J Cardiol. 2013;167:2688–2694.
29. Durack DT, Lukes AS, Bright DK., New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200–209.
30. Alonso-Valle H, Farinãs-Alvarez C, Garcıa-Palomo JD, et al. Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. J Thorac Cardiovasc Surg. 2010;139:887–893.
31. Bor DH, Woolhandler S, Nardin R, et al. Infective endocarditis in the U.S., 1998–2009: a nationwide study. PLoS One. 2013;8:e60033.
32. Funakoshi S, Kaji S, Yamamuro A, et al. Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. J Thorac Cardiovasc Surg. 2011;142:836–842.
33. Lalani T, Chu VH, Park LP, for the International Collaboration on Endocarditis–Prospective Cohort Study Investigators, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med. 2013;173:1495–1504.
34. Musci M, Weng Y, Hübler M, et al. Homograft aortic root replacement in native or prosthetic active infective endocarditis: Twenty-year single-center experience. J Thorac Cardiovasc Surg. 2010;139:665–673.
35. Kanafani ZA, Kanj SS, Cabell CH, et al. Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults. Eur J Clin Microbiol Infect Dis. 2010;29:1203–1210.
36. Sambola A, Fernández-Hidalgo N, Almirante B, et al. Sex differences in native-valve infective endocarditis in a single tertiary-care hospital. Am J Cardiol. 2010;106:92–98.
37. Chirouze C, Athan E, Alla F, on behalf of the International Collaboration on Endocarditis Study Group, et al. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect. 2013;19:1140–1147.
38. Martínez-Sellés M, Muñoz P, Arnáiz A, et al. Valve surgery in active infective endocarditis: a simple score to predictin-hospital prognosis. Int J Cardiol. 2014;175:133–137.
39. Da CM, Wollmann DR, Jr., Campos ACL, et al. Risk index for death by infective endocarditis: a multivariate logistic model. Braz J Cardiovasc Surg. 2007;22:192–200.
40. Gatti G, Perrotti A, Obadia JF, et al. Simple scoring system to predict in-hospital mortality after surgery for infective endocarditis. J Am Heart Assoc. 2017;6:e004806.
41. Olmos C, Vilacosta I, Habib G, et al. Risk score for cardiac surgery in active left-sided infective endocarditis. Heart. 2017;103:1435–1442.
42. Di Mauro M, Dato GMA, Barili F, et al. A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis. The EndoSCORE. Int J Cardiol. 2017;241:97–102.
43. De Feo M, Cotrufo M, Carozza A, et al. The need for a specific risk prediction system in native valve infective endocarditis surgery. ScientificWorld J. 2012;2012:307571.
44. Wang T, Oh T, Voss J, et al. Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditis. Heart Vessels. 2015;30:227–234.
45. Balsam L, Grossi EA, Greenhouse DG, et al. Reoperative valve surgery in the elderly: predictors of risk and long-term survival. Ann Thorac Surg. 2010;90:1195–1201.
46. Leontyev S, Borger MA, Davierwala P, et al. Redo aortic valve surgery: early and late outcomes. Ann Thorac Surg. 2011;91:1120–1126.
47. Perrotta S, Aljassim O, Jeppsson A, et al. Survival and quality of life after aortic root replacement with homografts in acute endocarditis. Ann Thorac Surg. 2010;90:1862–1868.
48. Rouzé S, Flécher E, Revest M, et al. Infective endocarditis with paravalvular extension: 35-year experience. Ann Thorac Surg. 2016;102:549–555.
49. Hill EE, Herregods MC, Vanderschueren S, et al. Outcome of patients requiring valve surgery during active infective endocarditis. Ann Thorac Surg. 2008;85:1564–1570.
50. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011;32:2027–2033.